Trade Results

BGC Group Inc caught our attention following a record-breaking earnings report, with revenue up 32% year-over-year and a 92% surge in their Energy, Commodities & Shipping segment - combined with bullish forward guidance pointing to continued momentum into 2026. See the details and what actions we took.

SRFM came onto our radar due to a cluster of insider buying activity all during an active $100M restructuring. A compelling setup, but one that came with a significant dilution risk attached. See how we at Atlantic trading handled the trade.

This stock is a prime example of a momentum play captured by one of our traders. It also shows how a company with a small market capitalization may be affected by news from large firms. In this case, it was APLD.

This trade exemplifies the power of catalyst-driven biotech plays when proper risk management is applied. The technical setup showed accumulation patterns before the FDA announcement, signaling institutional interest. A 400% gain in 7 days demonstrates why biotech catalysts remain one of the most explosive trading opportunities.